Immunosuppressive Medication Adherence in Kidney Transplant Recipients During the COVID-19 Pandemic: A

Chi Yuen Cheung1, Koon Ming Chan1, Gloria Tang1

  • 1Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China.

Transplantation Proceedings
|September 5, 2021
PubMed

Insights

The COVID-19 pandemic did not significantly impact immunosuppressive medication adherence in kidney transplant recipients. Good family support positively influenced adherence, with marital status being a key factor.

Area of Science:

  • Nephrology
  • Transplantation
  • Infectious Diseases

Background:

  • The COVID-19 pandemic strained global healthcare systems.
  • Kidney transplant recipients (KTRs) faced concerns regarding immunosuppressive medication (IM) adherence due to limited access to care and infection risks.
  • This study aimed to assess IM nonadherence dimensions in KTRs during the pandemic.

Purpose of the Study:

  • To determine the prevalence and patterns of immunosuppressive medication nonadherence in kidney transplant recipients.
  • To identify sociodemographic factors associated with immunosuppressive medication nonadherence.
  • To evaluate the impact of the COVID-19 pandemic on medication adherence in this population.

Main Methods:

  • A single-center, cross-sectional study was conducted.
  • Convenient sampling included kidney transplant recipients followed at Queen Elizabeth Hospital, Hong Kong.
  • Self-reported questionnaires and medical records were used to assess IM adherence and sociodemographic factors.

Main Results:

  • Out of 210 participants, 35.2% reported IM nonadherence in the 4 weeks prior to survey.
  • Timing adherence was the most common nonadherence pattern (30.1%).
  • Marital status was identified as an independent risk factor for IM nonadherence (OR, 1.97; P=.03).

Conclusions:

  • The COVID-19 pandemic did not significantly affect immunosuppressive medication adherence in kidney transplant recipients.
  • All patients continued their immunosuppressive medication throughout the pandemic.
  • Strong family support emerged as a positive influence on treatment adherence.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
107
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
99
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
92
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
423
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
173
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
92